Clarus Lifesciences III, L.P. - Insider Trading & Ownership

Entity
Company
Location
101 Main Street, Suite 1210, Cambridge, MA
Summary
The estimated value of insider holdings of Clarus Lifesciences III, L.P. is at least $212M dollars as of April 1, 2022. Clarus Lifesciences III, L.P. is the 10%+ Owner of Praxis Precision Medicines, Inc. and owns shares of Praxis Precision Medicines, Inc. (PRAX) stock worth about $123M. Clarus Lifesciences III, L.P. is the 10%+ Owner of Imago BioSciences, Inc. and owns shares of Imago BioSciences, Inc. stock worth about $85.5M. Clarus Lifesciences III, L.P. is the 10%+ Owner of Talaris Therapeutics, Inc. and owns shares of Tourmaline Bio, Inc. (TRML) stock worth about $2.72M.
All Insider Reports
All Insider Reports

Ownership of Clarus Lifesciences III, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PRAX Praxis Precision Medicines, Inc. 10%+ Owner $123M May 12, 2021
IMGO Imago BioSciences, Inc. 10%+ Owner $85.5M Mar 30, 2022
TRML Tourmaline Bio, Inc. 10%+ Owner $2.72M May 11, 2021

Insider Transactions Reported by Clarus Lifesciences III, L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.